ScholarX: LEE, WOO YONG

Detailed Information

LEE, WOO YONG (이우용)

Medicine (Medicine)

Research Area

Tel 02-3410-0261(1669)
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Colorectal cancer:25||Rectal cancer:20||colorectal cancer:19||Survival:13||Rectal neoplasms:11||Recurrence:10||Colon cancer:10||rectal cancer:10||colon cancer:9||Prognosis:9||Colorectal neoplasms:9||Neoadjuvant chemoradiotherapy:7||prognosis:6||survival:6||recurrence:5||chemotherapy:5||Preoperative chemoradiotherapy:4||Colorectal neoplasm:4||Chemoradiotherapy:4||Laparoscopy:4||Tumor budding:3||Colectomy:3||oncologic outcome:3||Diseasefree survival:3||Learning curve:3||Surgery:3||colorectal neoplasms:3||Neoadjuvant therapy:3||Radiotherapy:3||Chemotherapy:3||immunohistochemistry:3||Adjuvant chemotherapy:3||Metastasis:3||Colorectal surgery:3||lymph node metastasis:3||Microsatellite instability:3||prognostic factor:2||Local excision:2||Stage IIIA:2||metastasis:2||Radiation effects:2||microsatellite instability:2||Preoperative chemoradiation:2||radiotherapy:2||Postoperative complications:2||rectal neoplasm:2||Total mesorectal excision:2||tumor microenvironment:2||Colon:2||Morbidity:2||Longterm outcome:2||Lymph node metastasis:2||Lymphovascular invasion:2||s disease:2||Perineural invasion:2||Lynch syndrome:2||BAT26:2||Treatment:2||anastomotic leakage:2||Abdominoperineal resection:2||MMR:2||Oncologic outcome:2||MR imaging:2||Anastomotic leak:2||Simvastatin:2||MSI:2||carcinoembryonic antigen:2||Korea:2||BAT25:2||stage IV:2||Risk factor:2||surgery:2||Risk factors:2||Infliximab:2||Mononucleotide markers:2||Overall survival:2||Robotic surgical procedures:2||liver metastasis:2||local excision:2||Crohn&apos:2||neoadjuvant chemoradiotherapy:2||Pathology:2||Laparoscopic:2||Minimally invasive surgery:2||Liver metastasis:2||Carcinoembryonic antigen:2||FOLFOX:2||Leukopenia:2||Prognostic factor:2||COVID19:2||Natural orifice specimen extraction surgery:2||preoperative chemoradiotherapy:2||Histological grade:2||Multiple:2||Exfoliated cancer cells:1||Fungating tumor:1||Galectin1:1||Gastric cancer:1||General surgery:1||Genetically engineered mouse model:1||Genomic profile:1||Genomic test:1||Glasgow prognostic score:1||Guideline:1||HLADR expression on monocytes:1||HNPCC:1||Handassisted:1||Handassisted laparoscopic anterior resection (HALAR):1||Health informatics:1||Health policy:1||Health sciences:1||Health service:1||Hepatectomy:1||Hereditary colorectal cancer:1||High grade:1||Holistic integrative medicine:1||Human betadefensins2:1||Humans:1||Immunohistochemical markers:1||Immunology:1||Inflammatory bowel disease:1||Inflammatory marker:1||Intestinal obstruction:1||Intramucosal carcinoma:1||Intraoperative staging:1||Irradiated feeder cells:1||KRAS:1||Laparoscopic colorectal surgery:1||Laparoscopicassisted surgery:1||Lateral lymph node:1||Lateral pelvic recurrence:1||Leakage:1||Liver metastases:1||Local:1||Local anesthetics:1||Local recurrence:1||MMP2:1||MMP9:1||MRI:1||Magnet:1||Magnetic resonance imaging:1||Medical education:1||Mesenchymal stem cell:1||Mesorectalfascia:1||Metastases:1||Metastatic colorectal cancer:1||Metformin:1||Micropapillary pattern:1||Microsatellite instability (MSI):1||Minimally invasive surgical procedures:1||Modified complete mesocolic excision:1||Molecular ta:1||Monofix (R):1||Mouse model:1||Mucinous adenocarcinoma:1||Multivisceral resection:1||Muscle contraction:1||Mushroom cap&apos:1||MutL homolog 1 (MLH1):1||N staging:1||NOTES:1||Neoadjuvant:1||Neoadjuvant chemoradiation therapy (CRT):1||Neoadjuvant treatment:1||Neoajduvant treatment:1||Neoplasm staging:1||Neuroendocrine carcinoma:1||Neurotoxicity:1||Normal tissues adjacent to tumors:1||Obstruction:1||Old age:1||Oncologic outcomes:1||Oncology:1||Open surgery:1||Orthotopic model:1||Ovarian carcinoma:1||Ovarian metastasis:1||Ovarian metastatectomy:1||Oxaliplatin:1||Oxaliplatinresistance:1||PDGFRA:1||PET:1||PPI network:1||Pancreas:1||Pathologic complete response:1||Pathologic correlation:1||Patient safety:1||Patientderived cancer models:1||Patientderived cell:1||Patientderived tumor cells:1||Patientderived xenografts:1||Pelvic recurrencepalliative radiation therapy:1||Peritoneal Reflection:1||Physiology:1||Postoperative chemoradiotherapy:1||Postoperative pain:1||Preoperative chemoradiotherapy:1||Primary culture model:1||Primary tumor:1||Proctectomy:1||Proctocolectomy:1||Public health:1||Pulmonary metastasis:1||Quality improvements:1||RAS signature:1||RECK:1||RET fusion:1||Rectal neoplasm:1||Rectal surgery:1||Rectal washout:1||Rectum:1||Regorafenib:1||Resection:1||Residency:1||Residual cancer cells:1||Response:1||Restaging:1||Return to work:1||Rhoassociated coiledcoil containing protein kinase inhibitor:1||Rightsided colon cancer:1||Risk
factors:1||Risk Factors:1||Robotic TME:1||Robotic surgical procedure:1||Ropivacaine:1||SARSCoV2:1||SLC22A18:1||Sacral Promontory:1||Seprafilm (R):1||Signs and Symptoms:1||Simultaneous liver resection:1||Single port:1||Singleincision:1||Singleincision l:1||Singleincision laparoscopic surgery (SILS):1||Singleport access (SPA):1||Sizebased platform:1||Smads:1||Socioeconomic factors:1||Somatic mutation:1||Sphinctersaving surgery:1||Spleen:1||Stage II:1||Stage II colon cancer:1||Stage IIA colon cancer:1||Stage III colorectal cancer:1||Stoma:1||Submucosa:1||Submucosal tumor:1||Surgery alone:1||Surgical site infection:1||Surgical wound infection:1||Survival benefit:1||Synaptophysin:1||Synchronous:1||Systems biology:1||Tcell immunoglobulin and mucindomaincontaining molecule 3:1||T3N0:1||T3NOMO colon cancer:1||TAP block:1||TNM stage:1||Thymidylate synthase:1||Topdown st:1||Transabdominal robotic total mesorectal excision:1||Transanal TME:1||Transanal endoscopic microsurgery:1||Transanal endoscopic total mesorectal excision:1||Transanal specimen extraction:1||Transforming growth factor beta:1||Transoral specimen extraction:1||Transvaginal specimen extraction:1||Tumor heterogeneity:1||Tumor regression:1||Tumor response:1||Tumorinfiltrating immune cells:1||Tumour location:1||Twist1:1||Ulcerative colitis:1||Unemployment:1||Unresectable metastases:1||Validation:1||Vandetanib:1||Wait:1||Watch:1||Welldifferentiated rectal neuroendocrine tumors:1||Wide excision:1||Work:1||Xenograft:1||Xenografts:1||Young colorectal cancer:1||acute:1||adhesive ileus:1||adjuvant treatment:1||anal canal cancer:1||anaplastic lymphoma kinase (ALK) rearrangement:1||anastomotic leak in colorectal surgery:1||barbed suture:1||bevacizumab:1||bowel movement:1||cancer recurrence:1||cancer survivor:1||cecal injection:1||cell deconvolution:1||cellfree DNA (cfDNA):1||center dot Lymphovascular invasion:1||chemoradiation:1||chemoradiotherapy:1||cholecystectomy:1||chromogranin A:1||circumferential extent:1||clinical course:1||clinical outcome:1||cluster of differentiation 45 isoform RO:1||colon neoplasm:1||colorectal (colon) cancer:1||colorectal carcinoma:1||combined treatment:1||complications of the primary tumor:1||consensus:1||conversion:1||da Vinci SP<sup>®</sup>system:1||diabetes mellitus:1||diffuse large B cell lymphoma:1||digital sequencing:1||distress at the diagnosis:1||drug response:1||early colorectal cancer:1||employment:1||epithelial to mesenchymal transition:1||foot drop:1||forkhead box P3:1||forkhead box protein 3:1||gallstones:1||gastric cancer:1||gene expression:1||genomic profile:1||genomic test:1||hMLH1:1||handassisted laparoscopic surgery:1||hereditary spastic paraplegia:1||highfieldstrength imaging:1||humanized mice:1||immune cell proportion:1||immune therapeutics:1||incisional hernia:1||incomplete obstruction:1||intestinal lymphoma:1||intrasplenic injection:1||knowledge:1||laparoscopic:1||laparoscopic low anterior resection:1||laparoscopy:1||liver:1||local recurrence:1||locally advanced rectal cancer (LARC):1||low anterior resection:1||lung:1||lung metastasis:1||lymph node:1||lymph nodes:1||lymphadenectomy:1||machine learning:1||magnet:1||metastases:1||monofilament polydioxanone suture:1||mucinous carcinoma:1||multiomics:1||natural orifice specimen extraction surgery:1||neoadjuvant CCRT:1||neoplasm:1||neoplasms:1||neuroendocrine differentiation:1||next generation sequencing:1||node negative:1||nomogram:1||obstruction:1||oncologic outcomes:1||operative time:1||organonachip models:1||organoids:1||organotypic tumor spheroid:1||organotypictumor spheroids:1||orthotopic model:1||p300:1||p53:1||palliative intervention:1||paraaortic lymphnode metastasis:1||pathological complete response (pCR):1||pathology:1||patientderived cancer model:1||patientderived xenografts:1||perineural invasion:1||postoperative chemotherapy:1||postoperative pain:1||preclinical cancer models:1||preoperative staging:1||prognostic factors:1||psychooncology:1||pulmonary metastasis:1||quality of life:1||radical resection:1||radical surgery:1||rectal neoplasms:1||rectum:1||reduced port surgery:1||repeated metastasectomy:1||resection of primary tumor:1||risk factors:1||screening:1||second primary cancer:1||siRNA:1||sidedness:1||sign:1||signet ring cell carcinoma:1||single incision laparoscopic surgery:1||single port laparoscopy:1||single port robot:1||singleincision laparoscopic surgery:1||singleincision laparoscopy:1||social stigma:1||spastic:1||stage:1||stage III:1||stage IV colorectal cancer:1||surgical resection:1||surveillance:1||survivin:1||survivorship:1||synaptophysin:1||total mesorectal excision:1||traction:1||transanal endoscopic microsurgery:1||transanal specimen extraction:1||transoral specimen extraction:1||transvaginal:1||transvaginal specimen extraction:1||tropis:1||tumor deposit:1||tumorinfiltrating lymphocyte:1||unresectable metastases:1||xenograft:1||건강검진:1||사회경제적 요인:1||&apos:1||연령 요인:1||":1||AJCC TNM stage:1||ATPbased chemotherapy response assay (ATPCRA):1||Adenocarcinoma:1||Adenosine triphosphate:1||Adhesion:1||Adhesion barrier:1||Adipose tissuederived stem cells:1||Adipose tissuederived stem cells (ASCs):1||Age factors:1||Anorectal melanoma:1||Artificial intelligence:1||Autologo:1||Autologous stem:1||BRAF:1||Biocomputational method:1||Bioinformatics:1||Biomarker:1||Biomarkers:1||Bisacodyl:1||Bundle:1||CA 199 antigen:1||CAPOX:1||CC chemokine:1||CCL7:1||CCR3:1||CEA:1||CMS:1||CT:1||CUSUM:1||Cancer survivors:1||Cancer systems biology:1||Capecitabine:1||Carcinogenesis:1||Carcinoma in Situ:1||Cellfree DNA (cfDNA):1||Cellular immunity:1||Cetuximab:1||Chemoradiation:1||Chemoradiation therapy:1||Chemotherapeutic agent:1||Chest Xray:1||Children:1||Chromogranin:1||Circulating tumor cells:1||Circumferential resection margin:1||Clinical T4:1||Clinical manifestations:1||Colon neoplasm:1||Colonic neoplasms:1||Colonoscopic resection:1||Colonoscopy:1||Colorectal:1||Colorectal cancer surgery:1||Colorectal cancer with liver metastases:1||Complete remission:1||Compliance:1||Complications:1||Computed tomography:1||Concurrent chemoradiotherapy:1||Conditionally reprogramming:1||Consensus:1||Constipation:1||Continuing medical education:1||Conventional laparoscopic anterior resection (CLAR):1||Conversion:1||CpG island methylator phenotype (CIMP):1||Crohn disease:1||Crosssectional studies:1||Cystadenocarcinoma:1||Cytokeratin:1||DNA methylation:1||DSML 3: Development/preproduction: Data science output has been rolled out/validated across multiple domains/problems:1||Deep rectosigmoid endometriosis:1||Diabetes:1||Digital sequencing:1||Distal resection margin:1||Double primary malignancies (DPM):1||Downstaging:1||Drug resistance:1||Drug response:1||Drug screening assay:1||Ecadherin:1||ERCC1:1||ERK:1||ERKJNK signaling:1||Early colon cancer:1||Early detection of cancer:1||Early rectal cancer:1||Education:1||Elastic netbased machine learning:1||Employment:1||Epithelialmesenchymal transition:1||

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE